A U.S. District Court ruled in favor of Biohaven and Yale, awarding them $4 million after finding Avilar Therapeutics and RA Capital guilty of misappropriating Yale's trade secret related to the MODA protein degradation platform. The court also found RA Capital breached its confidentiality agreement with Yale. The case stems from RA Capital's use of confidential information shared during investment talks to develop a competing drug program. This judgment formalizes the jury's verdict and may be subject to post-trial motions. Biohaven licensed the MODA technology from Yale to develop new therapies.
OpenSea has partnered with Perplexity Computer to provide live cross-chain market data covering over 25 blockchains. This integration allows Perplexity's AI to answer user queries about token and NFT trading activity using real-time onchain data from...
Chainlink (LINK) has gained 5.11% in 24 hours, trading near $11.89 with strong support at $11. A bullish pennant pattern suggests a possible breakout toward $15 if volume confirms. Charles Schwab announced it will add LINK, along with Solana and Aval...
Marvell Technology's shares fell 8% in premarket trading after its fiscal 2028 revenue outlook, projecting about 50% growth to $18 billion, fell short of investor expectations fueled by a recent Google partnership. The chipmaker reported a 37% year-o...
Stacks (STX) is positioning its native token as a high-potential Bitcoin investment by leveraging its roles in Bitcoin DeFi, transaction fees, BTC rewards through Stacking, and an upcoming Bitcoin Staking product. STX demand is tied to network activi...
Caledonia Mining Corporation saw its shares rise 4% after broker Cavendish reaffirmed a buy rating following significant resource upgrades in Zimbabwe. The company announced a maiden 500,000-ounce resource at its Motapa property near the Bilboes proj...
